Want to see BFRI full AI Analyst Report?
Total Valuation
Biofrontera has a market cap or net worth of $22.43M. The enterprise value is $15.06.
Market Cap$22.43M
Enterprise Value$15.06
Share Statistics
Biofrontera has 14,852,359 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,852,359
Owned by Insiders3.76%
Owned by Institutions13.57%
Financial Efficiency
Biofrontera’s return on equity (ROE) is -1.01 and return on invested capital (ROIC) is -53.81%.
Return on Equity (ROE)-1.01
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-53.81%
Return on Capital Employed (ROCE)-0.55
Revenue Per Employee468.60K
Profits Per Employee-118.38K
Employee Count89
Asset Turnover1.46
Inventory Turnover6.24
Valuation Ratios
The current PE Ratio of Biofrontera is ―. Biofrontera’s PEG ratio is 0.00810.
PE Ratio―
PS Ratio0.14
PB Ratio0.55
Price to Fair Value0.55
Price to FCF-0.43
Price to Operating Cash Flow-2.43
PEG Ratio0.00810
Income Statement
In the last 12 months, Biofrontera had revenue of 41.70M and earned -10.54M in profits. Earnings per share was -1.04.
Revenue41.70M
Gross Profit32.80M
Operating Income-9.15M
Pretax Income-10.51M
Net Income-10.54M
EBITDA-9.19M
Earnings Per Share (EPS)-1.04
Cash Flow
In the last 12 months, operating cash flow was -7.93M and capital expenditures -3.00K, giving a free cash flow of -7.93M billion.
Operating Cash Flow-7.93M
Free Cash Flow-7.93M
Free Cash Flow per Share-0.53
Dividends & Yields
Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change75.09%
50-Day Moving Average1.17
200-Day Moving Average0.96
Relative Strength Index (RSI)75.94
Average Volume (3m)249.99K
Important Dates
Biofrontera upcoming earnings date is Nov 18, 2026, Before Open (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
Biofrontera as a current ratio of 1.52, with Debt / Equity ratio of 125.99%
Current Ratio1.52
Quick Ratio1.40
Debt to Market Cap1.01
Net Debt to EBITDA0.03
Interest Coverage Ratio-20.24
Taxes
In the past 12 months, Biofrontera has paid 25.00K in taxes.
Income Tax25.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Biofrontera EV to EBITDA ratio is -0.61, with an EV/FCF ratio of -0.42.
EV to Sales0.13
EV to EBITDA-0.61
EV to Free Cash Flow-0.42
EV to Operating Cash Flow-0.42
Balance Sheet
Biofrontera has $4.67M in cash and marketable securities with $7.50M in debt, giving a net cash position of -$2.84M billion.
Cash & Marketable Securities$4.67M
Total Debt$7.50M
Net Cash-$2.84M
Net Cash Per Share-$0.19
Tangible Book Value Per Share$0.77
Margins
Gross margin is 84.45%, with operating margin of -21.94%, and net profit margin of -25.26%.
Gross Margin84.45%
Operating Margin-21.94%
Pretax Margin-25.20%
Net Profit Margin-25.26%
EBITDA Margin-22.04%
EBIT Margin-24.12%
Analyst Forecast
The average price target for Biofrontera is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast17.83%
EPS Growth Forecast73.13%